Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-09-010828
Filing Date
2009-07-13
Accepted
2009-07-13 07:14:10
Documents
2
Period of Report
2009-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 4843
2 ex24poavvukovic.txt EX-24.TXT 3633
  Complete submission text file 0001179110-09-010828.txt   10067
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Vukovic Vojo (Reporting) CIK: 0001466794 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 09941172